ArticleJournal of inflammation research2025

TIMP4 as a Potential Complementary Biomarker and Therapeutic Target in Membranous Nephropathy: A Multi-Omics Investigation with Clinical Validation.

Qingsong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.